Literature DB >> 21862456

Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan.

Hsuen-Fu Lin1, Yi-Hwei Li, Chih-Hsien Wang, Chu-Lin Chou, De-Jhen Kuo, Te-Chao Fang.   

Abstract

BACKGROUND: An increased incidence of cancer in chronic dialysis patients has not been confirmed in the Chinese population. The aim of this population-based study was to examine the risk of various types of cancers in chronic dialysis patients in Taiwan.
METHODS: Data of 92 348 chronic dialysis patients extracted from the National Health Institutes Research Database during 1997-2008 were analyzed. Patients newly diagnosed with end-stage renal disease, free of cancer and receiving dialysis for >3 months were eligible for inclusion in the study.
RESULTS: After a mean follow-up of 4.4 years, a new cancer was diagnosed in 4328 chronic dialysis patients. The standardized incidence ratio (SIR) of chronic dialysis patients was 1.4 [95% confidence interval (CI): 1.3-1.4] and annual incidence of cancer was 1.1%. A trend of an increased SIR of cancer was observed in young patients and within the first year of dialysis. Bladder cancer carried the highest SIR (SIR: 8.2, 95% CI: 6.7-9.9) and had the highest frequency (21.2%). Importantly, the frequency (15.3%) of liver cancer was the second highest and the SIR (SIR: 1.4, 95% CI: 1.2-1.5) of liver cancer in chronic dialysis patients was higher than that of their healthy counterparts. Unexpectedly, chronic dialysis patients had a significantly reduced risk of developing lung cancer.
CONCLUSION: Increased risk of cancer in chronic dialysis patients is confirmed in the Taiwanese population and it is necessary to develop different strategies for cancer screening in chronic dialysis patients among different ethnicities.

Entities:  

Mesh:

Year:  2011        PMID: 21862456     DOI: 10.1093/ndt/gfr464

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  41 in total

1.  Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.

Authors:  Anne M Butler; Andrew F Olshan; Abhijit V Kshirsagar; Jessie K Edwards; Matthew E Nielsen; Stephanie B Wheeler; M Alan Brookhart
Journal:  Am J Kidney Dis       Date:  2015-02-07       Impact factor: 8.860

2.  Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.

Authors:  Weifeng Shang; Liu Huang; Li Li; Xiaojuan Li; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  Mol Clin Oncol       Date:  2016-07-07

3.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

Review 4.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

5.  [Multiple synchronous urinary tract tumors in a hemodialysis patient].

Authors:  J Rabinovich; T Klotz
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

6.  Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.

Authors:  Hyung Woo Kim; Young Su Joo; Shin Chan Kang; Hee Byung Koh; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang; Jung Tak Park
Journal:  Sci Rep       Date:  2022-06-25       Impact factor: 4.996

7.  Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.

Authors:  S-L Liu; L Qi; W-Q Han; B-S Zhu; X Zhou; S-S Jiang; M-F Chen; Y Li; W He; L-F Liu; X-H Hu; Y Xie; F-H Zeng; X-B Zu
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

8.  Comparisons of medical utilizations and categorical diagnoses of emergency visits between the elderly with catastrophic illness certificates and those without.

Authors:  Yang Nan-Ping; Lee Yi-Hui; Chung Chi-Yu; Hsu Jin-Chyr; Yu I-Liang; Chang Nien-Tzu; Chan Chien-Lung
Journal:  BMC Health Serv Res       Date:  2013-04-26       Impact factor: 2.655

9.  Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008.

Authors:  Shuo-Meng Wang; Ming-Nan Lai; Pau-Chung Chen; Yeong-Shiau Pu; Ming-Kuen Lai; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

10.  Are non-cardiac surgeries safe for dialysis patients? - A population-based retrospective cohort study.

Authors:  Yih-Giun Cherng; Chien-Chang Liao; Tso-Hsiao Chen; Duan Xiao; Chih-Hsiung Wu; Ta-Liang Chen
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.